Current and emerging biologics for the treatment of hereditary angioedema-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and emerging biologics for the treatment of hereditary angioedema

Published:2019-03-26 Issue:6 Volume:19 Page:517-526
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Perego Francesca¹,Wu Maddalena A.²³,Valerieva Anna⁴,Caccia Sonia²,Suffritti Chiara²,Zanichelli Andrea²³,Bergamaschini Luigi²⁵,Cicardi Marco²³

Affiliation:

1. IRCCS Istituti Clinici Scientifici Maugeri, Italy

2. Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy

3. ASST Fatebenefratelli Sacco, Milan, Italy

4. Clinical Centre of Allergology, University Hospital “Alexandrovska”, Medical University of Sofia, Bulgaria

5. Pio Albergo Trivulzio, Milan, Italy

Funder

not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1595581

Reference67 articles.

1. A biochemical abnormality in hereditary angioneurotic edema

2. The procoagulant and proinflammatory plasma contact system

3. In vivo roles of factor XII

4. Angioedema Phenotypes: Disease Expression and Classification

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor;Journal of Asthma and Allergy;2023-04

2. Long-term prophylaxis of hereditary angioedema with danazol;Chinese Medical Journal;2022-10-24

3. Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study;Frontiers in Pharmacology;2022-05-16

4. Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency;Expert Opinion on Emerging Drugs;2022-04-03

5. Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review;Clinical Immunology;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3